NCT03178032View on ClinicalTrials.gov

Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 26, 2017

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Brainstem GliomaNeoadjuvant Therapy
Interventions
BIOLOGICAL

DNX-2401

Brain infusion of the virus through the cerebellar peduncle

Trial Locations (1)

31190

Clinica Universidad de Navarra, Pamplona

Sponsors
All Listed Sponsors
collaborator

DNAtrix, Inc.

INDUSTRY

collaborator

Alcyone Therapeutics, Inc

INDUSTRY

lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

NCT03178032 - Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas | Biotech Hunter | Biotech Hunter